MedPath

Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive Episode

Phase 2
Completed
Conditions
Major Depressive Disorder
Registration Number
NCT00807105
Lead Sponsor
Shalvata Mental Health Center
Brief Summary

This is a prospective open label study of acute and maintenance treatment of MDD. The acute phase consists of daily treatments for 4 weeks. maintenance will be twice a week for eight weeks followed by 10 weeks of once a week treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • MDD patients
Exclusion Criteria
  • risk factors for convulsions

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
response in HAMDS1 YEAR
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

ShalvataMHC

🇮🇱

Hod Hasharon, Israel

ShalvataMHC
🇮🇱Hod Hasharon, Israel
© Copyright 2025. All Rights Reserved by MedPath